Antibiotice makes redundant 6% of employees

Antibiotice Iasi, the third largest drug manufacturer on the local market, will lay off 100 employees this year, as part of a more extensive programme for rendering operations more effective, which also entails cutting costs by 5-7%. “We will offer compensations to around 100 people. Some of them will leave as part of an early retirement programme,” said Coca Cascaval, general manager of Antibiotice Iasi. At the end of last year, Antibiotice number over 1,500 employees. The manufacturer is the second one to announce such a move, after Zentiva’s commercial team was cut by 27% in the first half of this year, to 184 people, compared with 253 people during the same period of 2007. Cascaval came to the helm of Antibiotice in the spring of this year.